Jocelyn Y. Cheng, MD

Senior director of neuroscience clinical research at Eisai.

Articles by Jocelyn Y. Cheng, MD

Health Risks of Daylight Savings for the Medical and Patient Community: Jocelyn Y. Cheng, MD

February 27th 2024

One of the members of the American Academy of Sleep Medicine Public Safety Committee talked about the adverse events of daylight savings among both the clinical and patient community. [WATCH TIME: 5 minutes]

Latest Updated Articles

Jocelyn Y. Cheng, MD

Articles by Jocelyn Y. Cheng, MD

Health Risks of Daylight Savings for the Medical and Patient Community: Jocelyn Y. Cheng, MD

Latest Updated Articles

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Understanding Ocrelizumab’s Impact on Advanced Progressive MS: Insights From Dr. Gavin Giovannoni

Inside the Phase 3 MASCOT Trial: Lundbeck’s Push for the First Disease-Modifying MSA Therapy

FDA Clears Roche’s Elecsys pTau181 Test for Ruling Out Alzheimer-Related related Amyloid Pathology

Reinforce Ocrelizumab’s Role Across the Full Spectrum of More Advanced Progressive MS: Gavin Giovannoni, MBBCh, PhD, FCP, FRCP, FRCPath

Overviewing Phase 3 OPERETTA 2 Trial and Ocrelizumab’s Impact on Pediatric Multiple Sclerosis: Brenda Banwell, MD, FRCPC, FAAN